The Human Viral Respiratory Diseases dtec-RT-qPCR-Panel-4 comprises a series of specific targeted reagents designed for CoVID-19, Human influenza type A and B virus, and Human respiratory syncytial virus A/B detection by using qPCR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly, resulting in characterization of this outbreak as a pandemic. However, most of the respiratory diseases have common overlapping symptoms, and differentiation of the potential co-circulation of SARS-CoV-2, influenza, and Human respiratory syncytial virus (HRSV) could pose an unprecedented challenge to healthcare systems worldwide. Clinical laboratories need a rapid and accurate method to detect and differentiate among SARS-CoV-2, Influenza A, Influenza B and HRSV-A/B. This assay can differentiate the most common causes of viral respiratory diseases.

Kit Content and Prices

F100

MONODOSE